PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Market Analysis and Trades for 9/30

Shutdown Risk or Just Rebalancing?

PharmD_KS's avatar
PharmD_KS
Sep 29, 2025
∙ Paid
2
Share

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so the Discord option includes Substack content but a new Substack subscription does not include Discord access.

Be sure you have read the Starter Kit, including the free section even if you’re a paid subscriber. Trading Doggy Style Starter Kit

The weekly post for SPY 0.00%↑ and QQQ 0.00%↑ which includes a free video should be reviewed prior to this. Market Analysis for the Week of 9/28

There is a 7-day free trial available for the newsletter so feel free to use that to review the starter kit, weekly plan, and plan for tomorrow. I cannot do trials for the Discord at this time.

SPY 0.00%↑

After reclaiming 6700-6706 early in the overnight session, ES rallied all night making the 6719-6721 target by the Tokyo close. Europe continued the bid making it to, and finding a quick excursion above 6728.5-6731.5 before finding a decent seller premarket. The RTH high was capped by the 28.5-31.5 spot which came as NQ tagged really the last line of defense for sellers at the 24969-24980. From there the fade was on as ES came all the way back to 6700-6706 and the VWAP cluster from the weekly video. ES tagged Friday’s 4pm close and the VWAP cluster, but sellers (for now) found no traction below 6700-6706.

NQ came just shy of the weekly 759-777 and the VWAP cluster at low of day:

We did get a profile today which gives sellers a chance to break this back down and make things interesting tomorrow.

Paid Content Below or in the Discord

JOIN THE DISCORD

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Keep reading with a 7-day free trial

Subscribe to PharmD Capital Trading with PharmD_KS to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 PharmD_KS
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture